Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05562895 · ClinicalTrials.gov registry record
A Multicenter Study to Evaluate the Cios Spin and the Ion Endoluminal System for Pulmonary Nodule Biopsy
A clinical trial, sponsored by Intuitive Surgical.
- Completed
- Registry status
- 155
- Enrollment target
NCT05562895: Completed study, sponsored by Intuitive Surgical.
NCT05562895 is a clinical trial that has completed, run by Intuitive Surgical. The registered enrollment target is 155 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05562895 has completed, sponsored by Intuitive Surgical.
- COMPLETED
- Registry status
- 155 participants
- Enrollment target
Study Summary
The overall objective of this study is to evaluate procedure characteristics of pulmonary nodule biopsies using the integrated version of Cios Spin and the Ion Endoluminal System.
Primary Outcome
Defined as the sum of true positives and true negatives divided by the total number of nodules (or subjects) biopsied
Interventions
- DEVICE Ion Endoluminal System and Cios Spin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 155 participants |
| Start Date | 2022-12-31 |
| Est. Completion | 2025-08-31 |
What the finished NCT05562895 record still lists
NCT05562895 is an observational study that tracks outcomes without assigning an intervention. The registered 155 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Ion Endoluminal System and Cios Spin is the first listed.
NCT05562895 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05562895 about?
NCT05562895 is a clinical study titled "A Multicenter Study to Evaluate the Cios Spin and the Ion Endoluminal System for Pulmonary Nodule Biopsy". The overall objective of this study is to evaluate procedure characteristics of pulmonary nodule biopsies using the integrated version of Cios Spin and the Ion Endoluminal System.
What is the current status of trial NCT05562895?
This trial is currently completed. The enrollment target is 155 participants. The study started on 2022-12-31. Estimated completion is 2025-08-31.
What interventions are being tested in trial NCT05562895?
The interventions under investigation include: Ion Endoluminal System and Cios Spin (DEVICE).
Who is sponsoring clinical trial NCT05562895?
This trial is sponsored by Intuitive Surgical, which has 40 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03223610 · 155 participants · Phase 1
Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (ViPOR) in Relapsed/Refractory B-cell Lymphoma
- NCT05072483 · 155 participants
Natural History Study of CADASIL
- NCT05086497 · 155 participants · NA
WBSI Guided Personalized Delivery of TTFields
- NCT05412069 · 155 participants · NA
Trial to Evaluate Fecobionics in Fecal Incontinence (FI) (NORMAL and ABNORMAL-FI)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI